Impact of NSCLC metabolic remodeling on immunotherapy effectiveness
Abstract It is known that metabolic reprogramming (MR) contributes to tumorigenesis through the activation of processes that support survival of cells, proliferation, and grow in the tumor microenvironment. In order to keep the tumor proliferating at a high rate, metabolic pathways must be upregulat...
保存先:
主要な著者: | Lulu Lv (著者), Ruo han Huang (著者), Jiale Li (著者), Jing Xu (著者), Wen Gao (著者) |
---|---|
フォーマット: | 図書 |
出版事項: |
BMC,
2022-08-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
著者:: Yuntao Wang, 等
出版事項: (2022) -
The role of immunotherapy in early-stage and metastatic NSCLC
著者:: Attila Lieber, 等
出版事項: (2024) -
The role of chemoradiotherapy and immunotherapy in stage III NSCLC
著者:: Zsuzsanna Orosz, 等
出版事項: (2024) -
Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients
著者:: Luigi Della Gravara, 等
出版事項: (2021) -
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
著者:: Yanyan Xu, 等
出版事項: (2022)